Papers

7

Total Citations

216

H-Index

4

About

Christopher S. Saigal is a leading urologic oncologist and health services researcher whose work sits at the intersection of surgical innovation, patient-centered outcomes, and healthcare value. His research focuses on prostate and bladder cancer, with major contributions in three key areas: cost-effectiveness analysis, the application of novel technologies to surgical planning, and the use of informatics to improve quality measurement. Notably, Saigal pioneered the use of time-driven activity-based costing (TDABC) to reveal the true short- and long-term costs of treating low-risk prostate cancer—a study that has garnered 144 citations and reshaped how institutions evaluate value in cancer care. He also advanced the use of 3D virtual reality models for robotic partial nephrectomy, demonstrating how immersive visualization can enhance surgical planning. His work on natural language processing to automate the identification of bladder cancer patients undergoing radical cystectomy represents a significant step toward scalable, data-driven quality improvement. With a career spanning prospective multi-center studies on patient-reported outcomes after prostatectomy and rigorous analyses of financial margins in surgical reimbursement, Saigal’s research consistently bridges clinical practice, technology, and policy—making him a pivotal figure in the modern transformation of urologic oncology.

Research Focus

Key Achievements

4
H-Index
7
Papers
216
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer
144 citations · 2015
📈 Most Prolific Year: 2007 (2 Papers)
🤝 Key Collaborators: 50
🏛 Institutions: University of California, Los Angeles, Ann Arbor Center for Independent Living

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago